Lakota et al have reported a significant increase in these autoantibodies in the sera of patients with tumours that spontaneously regressed after high‐dose therapy and autologous stem cell transplantation.21 Thus, the presence of autoantibodies against CA I in patients' sera could be put forward as a marker of a good prognosis. The gene discussed is CA1; the disease is neoplasm.